5ihl - Revision history

OCA at 13:53, 30 August 2023

OCA — Wed, 30 Aug 2023 13:53:22 GMT

←Older revision		Revision as of 13:53, 30 August 2023
Line 3:		Line 3:
	<StructureSection load='5ihl' size='340' side='right'caption='[[5ihl]], [[Resolution\|resolution]] 3.30Å' scene=''>		<StructureSection load='5ihl' size='340' side='right'caption='[[5ihl]], [[Resolution\|resolution]] 3.30Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[5ihl]] is a 8 chain structure with sequence from [https://en.wikipedia.org/wiki/~~Human Human~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5IHL OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5IHL FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[5ihl]] is a 8 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5IHL OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5IHL FirstGlance]. <br>
-	</td></tr><tr id='~~ligand~~'><td class="sblockLbl"><b>[[~~Ligand~~\|~~Ligands~~:]]</b></td><td class="sblockDat" id="~~ligandDat~~">~~<scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>~~</td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 3.3Å</td></tr>
-	<tr id='~~gene~~'><td class="sblockLbl"><b>[[~~Gene~~\|~~Gene~~:]]</b></td><td class="sblockDat">~~CD40, TNFRSF5 ([https~~:/~~/www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])~~</td></tr>	+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5ihl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ihl OCA], [https://pdbe.org/5ihl PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5ihl RCSB], [https://www.ebi.ac.uk/pdbsum/5ihl PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5ihl ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5ihl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ihl OCA], [https://pdbe.org/5ihl PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5ihl RCSB], [https://www.ebi.ac.uk/pdbsum/5ihl PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5ihl ProSAT]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==
-	[[https://www.uniprot.org/uniprot/TNR5_HUMAN TNR5_HUMAN]] Defects in CD40 are the cause of immunodeficiency with hyper-IgM type 3 (HIGM3) [MIM:[https://omim.org/entry/606843 606843]]. A rare immunodeficiency syndrome characterized by normal or elevated serum IgM levels with absence of IgG, IgA, and IgE. It results in a profound susceptibility to bacterial infections.<ref>PMID:11675497</ref>	+	[https://www.uniprot.org/uniprot/TNR5_HUMAN TNR5_HUMAN] Defects in CD40 are the cause of immunodeficiency with hyper-IgM type 3 (HIGM3) [MIM:[https://omim.org/entry/606843 606843]. A rare immunodeficiency syndrome characterized by normal or elevated serum IgM levels with absence of IgG, IgA, and IgE. It results in a profound susceptibility to bacterial infections.<ref>PMID:11675497</ref>
	== Function ==		== Function ==
-	[[https://www.uniprot.org/uniprot/TNR5_HUMAN TNR5_HUMAN]] Receptor for TNFSF5/CD40LG.	+	[https://www.uniprot.org/uniprot/TNR5_HUMAN TNR5_HUMAN] Receptor for TNFSF5/CD40LG.
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 30:		Line 30:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Human~~]]	+	[[Category: Homo sapiens]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: Sheriff, S]]	+	[[Category: Sheriff S]]
-	~~[[Category: Antitumor]]~~	+
-	~~[[Category: Cell surface receptor]]~~	+
-	~~[[Category: Domain antibody]]~~	+
-	~~[[Category: Immune system-signaling protein complex]]~~	+
-	~~[[Category: Protein/protein interaction~~]]	+

OCA at 06:44, 24 March 2021

OCA — Wed, 24 Mar 2021 06:44:51 GMT

←Older revision		Revision as of 06:44, 24 March 2021
Line 3:		Line 3:
	<StructureSection load='5ihl' size='340' side='right'caption='[[5ihl]], [[Resolution\|resolution]] 3.30Å' scene=''>		<StructureSection load='5ihl' size='340' side='right'caption='[[5ihl]], [[Resolution\|resolution]] 3.30Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[5ihl]] is a 8 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5IHL OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://proteopedia.org/fgij/fg.htm?mol=5IHL FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[5ihl]] is a 8 chain structure with sequence from [https://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5IHL OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5IHL FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
-	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">CD40, TNFRSF5 ([~~http~~://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>	+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">CD40, TNFRSF5 ([https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://proteopedia.org/fgij/fg.htm?mol=5ihl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ihl OCA], [~~http~~://pdbe.org/5ihl PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=5ihl RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/5ihl PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=5ihl ProSAT]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5ihl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ihl OCA], [https://pdbe.org/5ihl PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5ihl RCSB], [https://www.ebi.ac.uk/pdbsum/5ihl PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5ihl ProSAT]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==
-	[[~~http~~://www.uniprot.org/uniprot/TNR5_HUMAN TNR5_HUMAN]] Defects in CD40 are the cause of immunodeficiency with hyper-IgM type 3 (HIGM3) [MIM:[~~http~~://omim.org/entry/606843 606843]]. A rare immunodeficiency syndrome characterized by normal or elevated serum IgM levels with absence of IgG, IgA, and IgE. It results in a profound susceptibility to bacterial infections.<ref>PMID:11675497</ref>	+	[[https://www.uniprot.org/uniprot/TNR5_HUMAN TNR5_HUMAN]] Defects in CD40 are the cause of immunodeficiency with hyper-IgM type 3 (HIGM3) [MIM:[https://omim.org/entry/606843 606843]]. A rare immunodeficiency syndrome characterized by normal or elevated serum IgM levels with absence of IgG, IgA, and IgE. It results in a profound susceptibility to bacterial infections.<ref>PMID:11675497</ref>
	== Function ==		== Function ==
-	[[~~http~~://www.uniprot.org/uniprot/TNR5_HUMAN TNR5_HUMAN]] Receptor for TNFSF5/CD40LG.	+	[[https://www.uniprot.org/uniprot/TNR5_HUMAN TNR5_HUMAN]] Receptor for TNFSF5/CD40LG.
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 25:		Line 25:
	*[[Antibody 3D structures\|Antibody 3D structures]]		*[[Antibody 3D structures\|Antibody 3D structures]]
	*[[Tumor necrosis factor receptor 3D structures\|Tumor necrosis factor receptor 3D structures]]		*[[Tumor necrosis factor receptor 3D structures\|Tumor necrosis factor receptor 3D structures]]
		+	*[[3D structures of human antibody\|3D structures of human antibody]]
	== References ==		== References ==
	<references/>		<references/>

OCA at 07:18, 3 June 2020

OCA — Wed, 03 Jun 2020 07:18:53 GMT

←Older revision		Revision as of 07:18, 3 June 2020
Line 1:		Line 1:

	==STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH 3H56-5 DAB==		==STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH 3H56-5 DAB==
-	<StructureSection load='5ihl' size='340' side='right' caption='[[5ihl]], [[Resolution\|resolution]] 3.30Å' scene=''>	+	<StructureSection load='5ihl' size='340' side='right'caption='[[5ihl]], [[Resolution\|resolution]] 3.30Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[5ihl]] is a 8 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5IHL OCA]. For a <b>guided tour on the structure components</b> use [http://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=5IHL FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[5ihl]] is a 8 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5IHL OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=5IHL FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=5ihl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ihl OCA], [http://pdbe.org/5ihl PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5ihl RCSB], [http://www.ebi.ac.uk/pdbsum/5ihl PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5ihl ProSAT]</span></td></tr>	+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">CD40, TNFRSF5 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=5ihl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ihl OCA], [http://pdbe.org/5ihl PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5ihl RCSB], [http://www.ebi.ac.uk/pdbsum/5ihl PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5ihl ProSAT]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==
Line 20:		Line 21:
	</div>		</div>
	<div class="pdbe-citations 5ihl" style="background-color:#fffaf0;"></div>		<div class="pdbe-citations 5ihl" style="background-color:#fffaf0;"></div>
		+
		+	==See Also==
		+	*[[Antibody 3D structures\|Antibody 3D structures]]
		+	*[[Tumor necrosis factor receptor 3D structures\|Tumor necrosis factor receptor 3D structures]]
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Human]]
		+	[[Category: Large Structures]]
	[[Category: Sheriff, S]]		[[Category: Sheriff, S]]
	[[Category: Antitumor]]		[[Category: Antitumor]]

OCA at 06:25, 26 July 2016

OCA — Tue, 26 Jul 2016 06:25:55 GMT

←Older revision		Revision as of 06:25, 26 July 2016
Line 5:		Line 5:
	<table><tr><td colspan='2'>[[5ihl]] is a 8 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5IHL OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5IHL FirstGlance]. <br>		<table><tr><td colspan='2'>[[5ihl]] is a 8 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5IHL OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5IHL FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5ihl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ihl OCA], [http://pdbe.org/5ihl PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5ihl RCSB], [http://www.ebi.ac.uk/pdbsum/5ihl PDBsum]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5ihl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ihl OCA], [http://pdbe.org/5ihl PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5ihl RCSB], [http://www.ebi.ac.uk/pdbsum/5ihl PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5ihl ProSAT]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==

OCA at 07:36, 20 June 2016

OCA — Mon, 20 Jun 2016 07:36:49 GMT

←Older revision		Revision as of 07:36, 20 June 2016
Line 11:		Line 11:
	== Function ==		== Function ==
	[[http://www.uniprot.org/uniprot/TNR5_HUMAN TNR5_HUMAN]] Receptor for TNFSF5/CD40LG.		[[http://www.uniprot.org/uniprot/TNR5_HUMAN TNR5_HUMAN]] Receptor for TNFSF5/CD40LG.
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Current clinical anti-CD40 biologic agents include both antagonist molecules for the treatment of autoimmune diseases, and agonist molecules for immuno-oncology, yet the relationship between CD40 epitope and these opposing biological outcomes is not well defined. This report describes the identification of potent antagonist domain antibodies (dAbs) that bind to a novel human-CD40 specific epitope which is divergent in the CD40 of non-human primates. A similarly selected anti-cynomolgus-CD40 dAb recognizing the homologous epitope is also a potent antagonist. Mutagenesis, biochemical, and X-ray crystallography studies demonstrate that the epitope is distinct from that of CD40 agonists. Both the human-specific and cynomolgus-specific molecules remain pure antagonists even when formatted as bivalent Fc-fusion proteins, making this an attractive therapeutic format for targeting hCD40 in autoimmune indications.
		+
		+	Functional antagonism of human CD40 achieved by targeting a unique species-specific epitope.,Yamniuk AP, Suri A, Krystek SR, Tamura J, Ramamurthy V, Kuhn R, Carroll K, Fleener C, Ryseck R, Cheng L, An Y, Drew P, Grant S, Suchard SJ, Nadler SG, Bryson JW, Sheriff S J Mol Biol. 2016 May 21. pii: S0022-2836(16)30169-3. doi:, 10.1016/j.jmb.2016.05.014. PMID:27216500<ref>PMID:27216500</ref>
		+
		+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
		+	</div>
		+	<div class="pdbe-citations 5ihl" style="background-color:#fffaf0;"></div>
	== References ==		== References ==
	<references/>		<references/>

OCA at 06:10, 2 June 2016

OCA — Thu, 02 Jun 2016 06:10:14 GMT

←Older revision		Revision as of 06:10, 2 June 2016
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry 5ihl is ON HOLD until Paper Publication~~	+	==STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH 3H56-5 DAB==
-		+	<StructureSection load='5ihl' size='340' side='right' caption='[[5ihl]], [[Resolution\|resolution]] 3.30Å' scene=''>
-	~~Authors: Sheriff, S.~~	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>[[5ihl]] is a 8 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5IHL OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5IHL FirstGlance]. <br>
-	~~Description:~~ STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH 3H56-5 DAB	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
-	[[~~Category~~: ~~Unreleased Structures~~]]	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5ihl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ihl OCA], [http://pdbe.org/5ihl PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5ihl RCSB], [http://www.ebi.ac.uk/pdbsum/5ihl PDBsum]</span></td></tr>
		+	</table>
		+	== Disease ==
		+	[[http://www.uniprot.org/uniprot/TNR5_HUMAN TNR5_HUMAN]] Defects in CD40 are the cause of immunodeficiency with hyper-IgM type 3 (HIGM3) [MIM:[http://omim.org/entry/606843 606843]]. A rare immunodeficiency syndrome characterized by normal or elevated serum IgM levels with absence of IgG, IgA, and IgE. It results in a profound susceptibility to bacterial infections.<ref>PMID:11675497</ref>
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/TNR5_HUMAN TNR5_HUMAN]] Receptor for TNFSF5/CD40LG.
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
	[[Category: Sheriff, S]]		[[Category: Sheriff, S]]
		+	[[Category: Antitumor]]
		+	[[Category: Cell surface receptor]]
		+	[[Category: Domain antibody]]
		+	[[Category: Immune system-signaling protein complex]]
		+	[[Category: Protein/protein interaction]]

OCA at 00:30, 11 May 2016

OCA — Wed, 11 May 2016 00:30:35 GMT

←Older revision		Revision as of 00:30, 11 May 2016
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 5ihl is ON HOLD	+	The entry 5ihl is ON HOLD until Paper Publication

	Authors: Sheriff, S.		Authors: Sheriff, S.

-	Description: STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH ~~A DAB (BMS-3H-56~~-5)	+	Description: STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH 3H56-5 DAB
	[[Category: Unreleased Structures]]		[[Category: Unreleased Structures]]
	[[Category: Sheriff, S]]		[[Category: Sheriff, S]]

OCA: Protected "5ihl" [edit=sysop:move=sysop]

OCA — Thu, 10 Mar 2016 02:20:27 GMT

Protected "5ihl" [edit=sysop:move=sysop]

←Older revision

Revision as of 02:20, 10 March 2016

OCA: New page: '''Unreleased structure''' The entry 5ihl is ON HOLD Authors: Sheriff, S. Description: STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH A DAB (BMS-3H-56-5) [[Category:...

OCA — Thu, 10 Mar 2016 02:20:25 GMT

New page: '''Unreleased structure''' The entry 5ihl is ON HOLD Authors: Sheriff, S. Description: STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH A DAB (BMS-3H-56-5) [[Category:...

New page

'''Unreleased structure'''

The entry 5ihl is ON HOLD

Authors: Sheriff, S.

Description: STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH A DAB (BMS-3H-56-5)
[[Category: Unreleased Structures]]
[[Category: Sheriff, S]]